Exchange: NASDAQ·Updated 02:44 PM EDT
RCEL logo

RCELAVITA Medical Inc

$5.08
$0.01
(0.20%)
Today
EarningsAug 6
Mkt Cap$156.65M
Vol248,951.00
News
all
press releases
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics (NASDAQ:LSTA)read more...
Benzinga
More News
Avita Medical (RCEL) Upgraded to Buy: Here's Why
Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
read more...
Benzinga
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Avita Medical from a "sell" rating to a "strong sell" rating in a report on Saturday...
MarketBeat
AVITA Medical Promotes Interim CEO Cary Vance To CEO
(RTTNews) - AVITA Medical, Inc. (RCEL), a therapeutic acute wound care company, Thursday announced that it has promoted Cary Vance to the role of Chief Executive Officer and President, effective immediately...
Nasdaq News: Markets
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of "Hold" from Analysts
Shares of Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold re...
MarketBeat
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?
Avita Medical (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Avita Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital
D. Boral Capital restated a "buy" rating and issued a $10.00 target price on shares of Avita Medical in a research note on Wednesday...
MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) has earned an average rating of "Hold" from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One equities...
MarketBeat
Northland Securities Predicts Avita Medical Q1 Earnings
Avita Medical Inc. (NASDAQ:RCEL - Free Report) - Equities research analysts at Northland Securities issued their Q1 2026 earnings estimates for Avita Medical in a research note issued on Thursday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.